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NEW & NOTEWORTHY

Mutation of the HCN4 molecule is involved in gain or loss of pacemaker cell function. Here we show that this gain or loss is due not only to changes in the funny current activity but is also due to the resulting changes in the interaction between internal heart pacemaker mechanisms.
THE RECENT CARDIAC PACEMAKER cell function paradigm incorporates the concept of a coupled-clock system that integrates molecular cues on the cell membrane surface (i.e., membrane clock) and on the sarcoplasmic reticulum (SR) (Ca 2ϩ clock) [this concept is reviewed in Yaniv et al. (16) ]. Experimental and theoretical analyses have demonstrated that dysfunction even of a single molecular component relating to a specific mechanism in one clock will indirectly affect the mechanisms of the other clock and will lead to an increase in spontaneous action potential (AP) cycle length (17, 18) . Thus, loss or gain of pacemaker function is not merely the direct effect of a single mutation in a specific clock mechanism, but rather it is the net effect of changes in the function of coupled-clock pacemaker mechanisms. Mutations that decrease the degree of coupling between the two clocks will lead to a loss of normal pacemaker function, whereas mutations that increase the degree of clock coupling will lead to a gain of pacemaker function. (10, 19) . cAMP activates the funny current (I f ) function, an important component of the membrane clock, by positively shifting the f-channel activation curve (6) . In addition, the high basal rate of cAMP production controls PKAdependent phosphorylation activity. PKA, together with Ca 2ϩ -activated calmodulin-dependent kinase II (CaMKII) kinases, phosphorylates various membrane clock [e.g., L-type (12) and K ϩ currents (7)], as well as Ca 2ϩ clock proteins [phospholamban (PLB) and ryanodine receptors] (9). Recent evidence has associated PKA activity with pacemaker function (14) . Therefore, the amplitude and phase of the LCR Ca 2ϩ events sensed by the M-clock proteins, together with the PKA activity sensed by the proteins of both clocks, determine the degree of synchronization between the clocks and, consequently, the functioning of the coupled-clock system. The key nodal mechanisms, Ca 2ϩ and AC-cAMP-PKA signaling, affect and are affected by the AP firing rate. A decrease in the spontaneous AP beating interval, by disturbance of either mechanism on the membrane or in the Ca 2ϩ clock, will lead to enhanced SR Ca 2ϩ load, increased LCR amplitude, a higher degree of synchronization of the LCR Ca 2ϩ signal, and higher activation of the AC-cAMP-PKA phosphorylation cascade. Higher activation of the post-translation modification cascade further enhances the SR Ca 2ϩ load through an increase in PLB phosphorylation and further decreases the AP beating interval. Thus, initial gain of function in the coupled-clock system, even due to a change in a single clock component, increases the nodal signaling, which further increases the gain of function in steady state. The opposite occurs in the case of an increase in the spontaneous AP beating intervals.
A recent study (13) has shown that cotransfection of spontaneous beating cells (HEK293 cells and neonatal rat ventric-ular myocytes) with R524Q-mutant human hyperpolarizationactivated cyclic nucleotide-gated molecules (the dominant component of funny channels) increases the funny channel's sensitivity to cAMP and leads to a decrease in spontaneous AP cycle length (i.e., tachycardia). Expression of this mutation in patients was associated with symptoms of inappropriate sinus tachycardia (IST). The authors concluded that IST associated with this mutation is attributable to increased cAMP sensitivity of the f-channels, which leads to a shift in the funny current I f activation curve and an increase in the current density. Indeed, the R524Q-mutant funny channels have been shown to bear a higher cAMP sensitivity than wild-type channels and as a consequence carry a larger current than normal during the early diastolic depolarization, resulting in a shorter action potential beating interval. Because IST is directly related to dysfunction of the sinoatrial node, R524Q-mutant funny channels should lead to IST-associated symptoms in pacemaker cells. However, in pacemaker cells it is unclear whether expression of the mutant funny channels is the sole contributor to inappropriate tachycardia and what other mechanisms might indirectly contribute to this phenomenon.
We hypothesize that similar to neonatal rat ventricular myocytes, the R524Q-mutant rabbit sinoatrial node cells will exhibit tachycardia and, because the pacemaker function is determined by a coupled-clock system, the resultant steady-state decrease in AP cycle length will embody contributions of both clocks: the initial decrease in the spontaneous AP beating interval, arising from increased sensitivity of the f-channel to cAMP, will be accompanied by an increase in the AC-cAMP-PKA-dependent phosphorylation activity, which will further decrease the spontaneous AP beat interval. Our numerical model results show that even if a specific mutation in a gene that regulates the cAMP sensitivity of the f-channel exists, the resultant steady-state decrease in AP cycle length still embodies contributions of both clocks. Therefore, we provide evidence that IST indeed occurs as a direct consequence of the mutation in the funny channel, but that the interaction between internal pacemaker mechanisms through AC-cAMP-PKA-dependent phosphorylation signaling indirectly increases its severity.
MATERIALS AND METHODS
We used the recently developed Yaniv-Lakatta (YL) sinoatrial node cell numerical model (14) to test our hypothesis. This numerical model makes it possible to predict the dynamics of cAMP signaling, as well as the kinetics and magnitude of protein phosphorylation in both normal and mutant pacemaker cells. The model integrates our previous, experimentally measured levels of steady-state AC activity, cAMP and phosopholamban phosphorylation levels, and the dynamics of PKA activity in response to drug perturbations. Our numerical cAMP-PKA-coupled clock model includes 37 first-order differential equations. The YL model was updated to integrate the equations of the cAMP-induced I f activation curve, as in Fig. 5D in Baruscotti et al. (1) . The software was developed in MATLAB (The MathWorks, Natick, MA). Numerical integration was performed using the MatLab ode15s stiff solver, and the model simulations were run for 300 s to ensure that steady state was reached. Computation was performed on an Intel(R) Core i7-4790 CPU at 3.60 GHz machine with 8 GB of RAM. A random search (2, 3) was performed to search for values of the conductance parameters, g CaL,max, gIf,max, and of the sarcoplasmic reticulum Ca 2ϩ -ATPase pumping constant, Pup,max, which together yield a Ͼ8% difference in AP beating interval between the wild-type and the R524Q channel-bearing cells. This was done while the phosphodiesterase (PDE) activity was lowered to below its basal value, to allow cAMP levels to rise [thus simulating pharmacological treatment with the isobutylmethylxanthine (IBMX) PDE inhibitor] and reach the activation range of If, where a shift between activation of the wild-type versus the R524Q channels is nonnegligible, i.e., corresponded to the range cAMP ϭ 0.001-10 M in Fig. 5D in Baruscotti et al. (1) . Of note, the cAMP levels provided in Baruscotti et al. (1) were assumed to be presented as the level over basal cAMP.
RESULTS
The numerical model simulation predicts that the R524Q mutation will lead to an 8.6% shorter spontaneous AP beating interval in pacemaker cells, compared with the wild-type cells (Fig. 1A) , corroborating experimental trends documented in HEK293 cells and in neonatal rat ventricular myocytes (1) . Increase in the sensitivity of HCN4 to cAMP results in an increase in the I f current, specifically during early diastolic depolarization (Fig. 1B) , subsequently increasing the Ca 2ϩ influx per unit time (Fig. 1C) . This increase in net Ca 2ϩ influx results in an increase in SR Ca 2ϩ load (Fig. 1, D-F) , and in a decrease in the restitution time required for spontaneous diastolic Ca 2ϩ releases to occur, i.e., the period of local Ca 2ϩ release is shortened (Fig. 1, G and H) . Consequently, the Ca 2ϩ -dependent activation of Na ϩ -Ca 2ϩ exchange current (I NCX ) occurs at lower voltage during early diastolic depolarization and with a larger amplitude (Fig. 1I) . This further decreases the AP firing-beating interval, leading to a further increase in Ca 2ϩ influx per unit time, until the Ca 2ϩ influx is balanced by an increase in Ca 2ϩ efflux via I NCX . In parallel, increased intracellular Ca 2ϩ levels in R524Q-mutant pacemaker cells lead to activation of CaMKII and Ca 2ϩ -activated AC-cAMP-PKA signaling axes. The numerical model predicts a small but significant increase in cAMP and PKA signaling (Fig. 1, J and K) in R524Q-mutant pacemaker cells. The resultant increase in phosphorylation of Ca 2ϩ -cycling proteins further increases both the net Ca 2ϩ influx through phosphorylation of L-type channels, and SR Ca 2ϩ load through phosphorylation of PLB (Fig. 1L) , which both further shorten the AP beating interval. The resultant increase in cAMP further shifts the I f activation curve, increasing cAMP sensitivity. Importantly, in R524Q-mutant pacemaker cells, the amplitude changes induced in L-type Ca 2ϩ current (I Ca,L )and I NCX by the afferent coupled-clock mechanisms were comparable to the changes in I f (Fig. 1, M-O) . A number of mechanisms limit the shortening of the AP beating interval in R524Q-mutant pacemaker cells and lead to a steady-state AP beating interval. First, I f is time-dependent current that reaches its maximal value only after 1 s. Therefore, when the activation period is shortened (i.e., shorter AP beating interval), I f cannot reach its maximal value and its contribution is mitigated. To further investigate the role of changes in Ca 2ϩ -activated AC-cAMP-PKA signaling in the development of tachycardia in R524Q-mutant pacemaker cells, we clamped, in the numerical model, the level of PKA in R524Q-mutant pacemaker cells to the basal level in wild-type pacemaker cells. The cAMP level was left to evolve freely. Clamping the PKA level reduced the decrease in cycle length by 56% in R524Q-mutant pacemaker cells ( Fig. 2A) : the AP cycle length was 368 ms when clamping the PKA level versus 349 ms for the non-PKA-clamped R524Q. In parallel, there was a reduction in the increased I f amplitude ( Fig. 2B) , I Ca,L amplitude (Fig. 2C) , SR Ca 2ϩ load and release (Fig. 2, D-G) , and I NCX amplitude (Fig. 2I) .
To show that an increase in AC-cAMP-PKA signaling could also lead to tachycardia similar to that documented in the R524Q mutation, we simulated the effect of IBMX to reduce the level of the PDE inhibitor. The decrease in spontaneous AP beating interval under IBMX treatment was similar to the one documented in R524Q-mutated pacemaker cells (Fig. 3A) . The I f amplitude was a little higher for the R524Q case (Fig. 3, B and O) due to the higher sensitivity of HCN4 to cAMP. Conversely, the I Ca,L and I NCX amplitudes were slightly higher under IBMX treatment (Fig. 3, C, M, and N) due to the higher level of cAMP-PKA, which increased Ca 2ϩ cycling (through the activation of the sarcoplasmic reticulum Ca 2ϩ -ATPase via PLB phosphorylation) and the activation of the L-type channels (Fig. 3, D-G and J-L) . To further investigate the role of changes in I f in the development of tachycardia in R524Q-mutant pacemaker cells, we clamped, in the numerical model, the level of cAMP that activates the I f to the basal level in wild-type, untreated pacemaker cells. The PKA level was left to evolve freely. Simulating IBMX treatment and clamping the cAMP level affecting the I f decreased the spontaneous AP firing beating interval only by 14% in wild type-treated pacemaker cells (Fig. 3A) . In parallel, there was a reduction in the increased I f amplitude (Fig. 3B) , I Ca,L amplitude (Fig. 3C) , SR Ca 2ϩ load and release (Fig. 3, D-G) , and I NCX amplitude (Fig.  3I) . Thus, this simulation illustrates that tachycardia could also be caused by any other mutation or change in autonomic modulation that would increase the level of AC-cAMP-PKA signaling. Therefore, Ca 2ϩ -activated AC-cAMP-PKA is a critical mediator of mutual clock entrainment.
To provide evidence of the role of changes in Ca 2ϩ -activated AC-cAMP-PKA signaling also in the development of bradycardia, we simulated a mutation that leads to reduced funny channel activity and to loss of function in cardiac pacemaker cells (11). Milanesi et al. (11) showed that mutant S672R channels respond normally to cAMP but that they are activated at more negative voltages. To illustrate this phenomenon, we reduced the halfactivation voltage of I f by 1 mV. The numerical model simulation predicts that the S672R mutation will lead to a 12% longer spontaneous AP beating interval in pacemaker cells (Fig. 4, A  and P) . Reduced HCN4 response to cAMP results in a decrease in the I f amplitude, specifically during early diastolic depolarization (Fig. 4B) , subsequently decreasing the Ca 2ϩ influx per unit time (Fig. 4C) . This decrease in net Ca 2ϩ influx results in a decrease in SR Ca 2ϩ load (Fig. 4, D-F) and in an increase in the restitution time required for spontaneous diastolic Ca 2ϩ releases to occur, i.e., the period of local Ca 2ϩ release is prolonged (Fig. 4, G and H) . Consequently, the Ca 2ϩ -dependent activation of I NCX occurs at higher voltages during early diastolic depolarization and with a smaller amplitude (Fig. 4I) . This further increases the AP firing-beating interval, leading to a further decrease in Ca 2ϩ influx per unit time, until the Ca influx is balanced by a decrease in Ca 2ϩ efflux via I NCX . In parallel, decreased intracellular Ca 2ϩ levels in S672R-mutant pacemaker cells lead to decreased activation of CaMKII and Ca 2ϩ -activated AC-cAMP-PKA signaling axes. The numerical model predicts a small but significant decrease in cAMP and PKA signaling (Fig. 4, J and K) in S672R-mutant pacemaker cells. The resultant decrease in phosphorylation of Ca 2ϩ cycling proteins further decreases both the net Ca 2ϩ influx through phosphorylation of L-type channels and SR Ca 2ϩ load through phosphorylation of PLB (Fig. 4L) , which both further prolong the AP beating interval. The resultant decrease in cAMP further shifts the I f activation curve, decreasing its activity. Similar to the case of R524Q-mutant pacemaker cells, the S672R-mutant pacemaker cell amplitude changes induced in I Ca,L and I NCX by the afferent coupled-clock mechanisms were comparable with the changes in I f (Fig. 4, M-O) . When we clamped, in the numerical model, the level of PKA in S672R-mutant pacemaker cells to the basal level in wild-type pacemaker cells, the bradycardia was almost completely suppressed (Fig. 4) .
DISCUSSION
Our first major conclusion is that R524Q-mutant pacemaker cells have a shorter AP firing rate than that of wild-type cells, and this gain in pacemaker function is the net effect of the R514Q mutation on the functioning of the coupled-clock system (Fig. 1) . The initial decrease in the spontaneous AP beating interval, mediated by an increase in the funny current due to increased cAMP sensitivity, leads to increased SR Ca 2ϩ load, an increased LCR amplitude, a higher degree of synchronization of the LCR Ca 2ϩ signal, and a higher level of the AC-cAMP-PKA phosphorylation cascade. The increase in the AC-cAMP-PKA phosphorylation cascade in turn leads to an increase in the funny current, Ca 2ϩ current, and SR Ca 2ϩ protein activities, and all of these components further decrease the spontaneous AP beating interval. Opposite results were documented in response to drugs that inhibit the funny channel (18) . Using numerical modeling, we predict for the first time that inappropriate tachycardia should be detected not only in mutant rat ventricular and HEK293 cells but, importantly, in R524Q-mutant sinoatrial pacemaker cells. Of note, the degree of tachycardia was smaller in pacemaker cells than in mutant rat ventricular and HEK293 cells. One possible explanation for the difference in the degree of tachycardia between different cell types is the level of expression of the funny channel: physiological level in pacemaker cells (13) and overexpression in the other types of cells. Note that the R524Q mutation in HCN4 was identified in IST patients; however, there may be other clock genes that are altered in these patients that also affect the degree of tachycardia. Further experimental analysis of pacemaker cells bearing the R524Q-HCN4 mutant are required to confirm the predictions of our model and to further understand this phenomenon.
Our second major conclusion is that cAMP/PKA signaling is an important component in the development of tachycardia in R524Q-mutant pacemaker cells (Figs. 2 and 3 ). This conclusion is based on the numerical simulation that made it possible to clamp the level of PKA in R524Q-mutant pacemaker cells to the basal level in wild-type pacemaker cells. Such an approach can be accomplished only by numerical modeling and not by any experimental tools that exist today. Furthermore, because it is challenging to culture pacemaker cells and to cotransfect them with human R524Q-mutant HCN4 channels, only a numerical model can help to resolve these research hypotheses. Finally, the changes in cAMP, PKA, and PLB phosphorylation (Fig. 2, J-L) were small and cannot be detected experimentally but only by a numerical model. Similarly, AC-cAMP-PKA signaling is predicted to be an important component in the development of bradycardia in S672R-mutant pacemaker cells (Fig. 4) .
Our results show that AC-cAMP-PKA signaling is involved in both gain and loss of pacemaker cell function. This may lead to important clinical insights: while drugs such as ivabradine can decrease the activity of I f (5), they do not directly affect its cAMP sensitivity. However, because an initial increase in the spontaneous AP firing beating interval in response to ivabradine leads to a decrease in AC-cAMP-PKA signaling (18) , cAMP can shift the I f activation curve in R524Q-mutant pacemaker cells. This eliminates the tachycardia effect. Reduction in AC-cAMP/PKA activity (e.g., by ␤-blockers) in parallel to treatment by ivabradine could make the treatment more putative (15) . Conversely, no existing drug can directly increase the activity of I f for S672R-mutant pacemaker cells. As predicted by the numerical simulations, IBMX will increase AC-cAMP-PKA signaling, which will compensate for the reduction in I f and therefore could be used to treat bradycardia of S672R-mutant pacemaker cells.
In conclusion, any mutant in any member of the membrane or Ca 2ϩ clock will affect cardiac pacemaker function because of not only a deficiency in the specific clock but also an altered mutual-clock function. Therefore, the steady-state bradycardia or tachycardia associated with HCN4 mutations or other clock gene mutations must be viewed as not only the outcome of modification of a single clock but also the consequence of altered clock cross talk. Only a complete understanding of the coupled mechanisms underlying heart rhythm disturbance will promote the discovery of effective treatments for patients suffering from tachy-brady cardiac rhythms.
